AGA Medical Holdings, which provides medical devices for the minimally invasive treatment of heart defects and vascular diseases, filed with the SEC for an IPO on Friday. The Minnesota-based company booked $148 million in LTM revenues and plans to apply for listing on the NASDAQ under the ticker AGAM. Citi, Deutsche Bank and Lehman Brothers are the lead underwriters on the deal. No terms were disclosed in the initial filing.
